Chloroquine & Hydroxychlorquine Rule

Ohio State of Ohio Board of Pharmacy passed a rule related to prescribing chloroquine and hydroxychloroquine for purposes of COVID-19.

Unless otherwise approved by the Board’s executive director, no prescription for chloroquine or hydroxychloroquine may be dispensed by a pharmacist or sold at retail by a licensed terminal distributor of dangerous drugs unless:

• The prescription bears a written diagnosis code from the prescriber;
• If written for a COVID-19 diagnosis, the diagnosis has been confirmed by a positive test result, which is documented on the prescription and both of the following apply:
• The prescription is limited to no more than a fourteen-day supply, and
• No refills may be permitted unless a new prescription is furnished.

Prescriptions for either presumptive positive patients or prophylactic use of chloroquine or hydroxychloroquine related to COVID-19 is strictly prohibited unless otherwise approved by the Board’s Executive Director in consultation with the Board President, at which time a resolution shall issue.